The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ICARUS-LUNG01: A phase 2 study of datopotomab deruxtecan (Dato-DXd) in patients with previously treated advanced non-small cell lung cancer (NSCLC), with sequential tissue biopsies and biomarkers analysis to predict treatment outcome.
 
David Planchard
Honoraria - PeerVoice; Prime Oncology
Consulting or Advisory Role - Abbvie; Anheart Therapeutics; AstraZeneca; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Janssen; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche; Samsung; Seagen
Research Funding - Abbvie (Inst); AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Janssen (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Pierre Fabre (Inst); Roche (Inst); Sanofi/Aventis (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst)
 
Nathalie Cozic
No Relationships to Disclose
 
Marie Wislez
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Janssen Oncology; MSD Oncology; Roche; Sanofi
Speakers' Bureau - Amgen; Amgen; AstraZeneca; Bristol-Myers Squibb; Janssen Oncology; MSD Oncology; Roche; Sanofi
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - Janssen Oncology; Roche
 
Christos Chouaid
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen Oncology; MSD; Novartis; Pfizer; Roche; Takeda
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD; Roche
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Janssen medical Affairs; MSD (Inst); Novartis (Inst); Pfizer (Inst); Pierre Fabre (Inst); Roche (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Pfizer; Roche
 
Hubert Curcio
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - BMS GmbH & Co. KG
Research Funding - Daiichi Sankyo Europe GmbH (Inst); Gilead Sciences (Inst); Janssen (Inst); Mirati Therapeutics (Inst); Shanghai Allist Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Sandoz
 
Sophie Cousin
Honoraria - AstraZeneca; MSD Oncology; Sanofi; Takeda
Consulting or Advisory Role - Janssen Oncology
Travel, Accommodations, Expenses - AstraZeneca; MSD Oncology; Pfizer; Takeda
 
Celine Mascaux
No Relationships to Disclose
 
Jacques Cadranel
Honoraria - AstraZeneca/MedImmune; Bristol-Myers Squibb; Merck Sharp & Dohme
Consulting or Advisory Role - Abbvie (Inst); Amgen; AstraZeneca/MedImmune; Janssen; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Sanofi (Inst); Takeda
Research Funding - Pfizer (Inst)
 
Margaux Geier
No Relationships to Disclose
 
Maria Rosa Ghigna
No Relationships to Disclose
 
Ghada Nachabeh
No Relationships to Disclose
 
Ricardo F. Zwirtes
No Relationships to Disclose
 
Rachel Chiaverelli
Employment - Daiichi Sankyo/Astra Zeneca
Stock and Other Ownership Interests - Daiichi Sankyo/Astra Zeneca
 
Rasha Cheikh-Hussin
No Relationships to Disclose
 
Noemie Corcos
No Relationships to Disclose
 
Fernanda Mosele
Employment - PEGASCY
Consulting or Advisory Role - Novartis (Inst)
 
Fabrice Andre
Consulting or Advisory Role - AstraZeneca (Inst); Boston Pharmaceuticals (Inst); Daiichi Sankyo (Inst); Gilead Sciences (Inst); Guardant Health (Inst); Lilly; Lilly (Inst); N-Power Medicine (Inst); Novartis (Inst); Owkin (Inst); Pfizer (Inst); ROCHE (Inst); SERVIER (Inst)
Research Funding - AstraZeneca (Inst); Daiichi (Inst); Guardant Health (Inst); Lilly (Inst); Novartis (Inst); Owkin (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; Novartis; Roche
 
Guillaume Montagnac
No Relationships to Disclose
 
Barbara Pistilli
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/UCB Japan; Myriad Genetics; Novartis; PIERRE FABRE; Puma Biotechnology
Research Funding - AstraZeneca (Inst); DAIICHI-SANKYO (Inst); Gilead Sciences (Inst); Merus (Inst); Pfizer (Inst); Puma Biotechnology (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Europe GmbH; MSD Oncology; Novartis; Pfizer; Pierre Fabre